Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -0.45% |
| 2024 | 43.12% |
| 2023 | 2.71% |
| 2022 | 24.42% |
| 2021 | 38.95% |
| 2020 | 47.40% |
| 2019 | 43.68% |
| 2018 | 33.71% |
| 2017 | 23.63% |
| 2016 | 38.81% |